摘要
[目的]了解胃肠癌化疗病人的症状频率、严重度、困扰度以及生活质量现状,以期为提高胃肠癌化疗病人的症状管理,改善其生活质量提供理论依据。[方法]本研究为横断面描述性设计,方便抽样法,采用症状评估量表(MSAS)以及FACT-G量表对494例胃肠癌化疗病人进行测评。[结果]胃肠癌化疗病人生理症状负担得分为(1.15±0.58)分,心理症状负担得分为(0.62±0.36)分,总困扰指数得分为(1.35±0.62)分,MSAS总分为(0.92±0.45)分;生活质量得分为(67.87±11.17)分;(除社会/家庭维度与生理状况维度无相关性外)症状负担各维度得分与生活质量得分均有相关性;多元回归结果显示,生理症状负担与心理症状负担均为生活质量较强的影响因素(R=0.590,P<0.001)。[结论]胃肠癌化疗病人的症状负担较重,生活质量不高,症状负担某些维度可以较好地预测生活质量,医务人员应重视对病人症状负担的评估,探索有效的干预措施,以提高癌症病人的生活质量。
Objective:To know about the frequency the degree of severity,trouble degree of symptoms and statusquo of life quality of gastrointestinal cancer patients with chemotherapy,in order to provide a theoretical basis for improving the symptoms management of gastrointestinal cancer patient with chemotherapy,and improving their quality of life.Methods:This study was a cross-sectional descriptive design.The convenient sampling Method,the Symptom Assessment Scale(MSAS)and FACT-G scale were used to do a evaluation for 494 cases of gastric cancer patients undergoing chemotherapy.Results:The physical symptom burden score of gastric cancer with chemotherapy patients was(1.15±0.58),the mental symptom burden score was(0.62±0.36),general distress index score was(1.35±0.62),the total score of MSAS was(0.92±0.45);the score of quality of life was(67.87±11.17);symptom burden score of each dimension and quality of life score showed correlation;multiple regression showed that,physical symptom burden and psychological symptom burden were the strong influencing factors of life quality(R=0.590,P<0.001).Conclusion:The symptom burden of gastrointestinal cancer chemotherapy patients is heavier,but the quality of life is not high.Symptom burden in some dimensions can be used to predict the quality of life,and medical personnel should pay attention to the assessment of patients' symptom burden,to explore the effective intervention measures,so as to improve the quality of life of cancer patients.
出处
《护理研究（中旬版）》
2015年第7期2444-2448,共5页
Chinese Nursing Researsh
基金
上海市教育委员会科研创新项目
编号:14ZS166
关键词
胃肠癌
化疗
症状负担
生活质量
gastrointestinal cancer
chemotherapy
symptom burden
quality of life
